SRC and ovarian carcinoma: Meanwhile, there are c-Src binders that inactivate c-Src, such as DOC-2/DAB2 (differentially expressed in ovarian carcinoma-2/disabled-2) 13, C-terminal Src kinase (CSK) 14, E3 ubiquitin‐ligase Cbl 15, 16, and Cullin‐5 17.